Tata Elxsi and OpenAna have introduced AnaTel™, an innovative AI-native platform aimed at transforming regulatory-ready software engineering in the MedTech sector.
This platform was unveiled at DeviceTalks Boston 2026 and is designed to streamline compliance processes while significantly reducing the development timelines for Software as a Medical Device (SaMD). By leveraging autonomous AI agents, AnaTel™ can cut development cycles from eight weeks to just 72 hours, potentially increasing productivity by up to 60%.
AnaTel™ addresses the challenges of managing regulatory documentation and compliance, which often involve disparate tools and manual processes. By embedding compliance into the engineering workflow, the platform ensures that requirements, architecture, and validation are seamlessly integrated, thus eliminating bottlenecks that hinder efficiency.
The collaboration between Tata Elxsi and OpenAna combines decades of expertise in regulated medical environments with advanced AI capabilities. This partnership aims to set a new standard for AI-native platforms in the healthcare industry, balancing speed and safety while providing transparent and auditable engineering evidence for regulators.
As the demand for rapid and compliant software solutions grows, AnaTel™ represents a significant advancement in the MedTech landscape, allowing human experts to retain control while benefiting from AI-driven efficiencies.